by Hans Hogerzeil, Sanne Frost-Helt, Fumie Griego et al.
The Access to Medicine Foundation, 2017
The report presents the latest good practice framework for pharmaceutical companies working to improve access to medicine. Developed over the last year through internal analysis, stakeholder engagement and consultations through our committees, the methodology will track where and how pharmaceutical companies are taking action, including in strategy, compliance, R&D, pricing, patenting, donations and capacity building. The 2018 Access to Medicine Index will rank the same 20 pharmaceutical companies as in the 2016 Access to Medicine Index. Considering their size, resources, pipelines, portfolios and global reach, these companies have a critical role to play in improving access to medicine.